Results 81 to 90 of about 8,209,000 (311)

On the Stability of Linear Incommensurate Fractional-Order Difference Systems

open access: yes, 2020
To follow up on the progress made on exploring the stability investigation of linear commensurate Fractional-order Difference Systems (FoDSs), such topic of its extended version that appears with incommensurate orders is discussed and examined in this ...
Iqbal M. Batiha   +4 more
core   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli   +3 more
wiley   +1 more source

Difference-in-difference estimates of gender gaps in self-reported performance.

open access: yes, 2019
Difference-in-difference estimates of gender gaps in self-reported performance.
Marco A. Palma (5754044)   +2 more
core   +1 more source

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters   +17 more
wiley   +1 more source

Difference-in-difference estimates for mango producers, distributors & processors.

open access: yes
Difference-in-difference estimates for mango producers, distributors & processors.
Bright Ketadzo (18297587)   +4 more
core   +1 more source

Generalized Nonlinear Difference-in-Difference-in-Differences [PDF]

open access: yesSSRN Electronic Journal, 2019
The work of the first author was supported by Riksbankens Jubileumsfond, Grant M13-0559:1, PI: Staff an I. Lindberg, V-Dem Institute, University of Gothenburg, Sweden and by European Research Council, Grant 724191, PI: Staff an I. Lindberg, V-Dem Institute, University of Gothenburg, Sweden.
Glynn, Adam, Ichino, Nahomi
openaire   +2 more sources

Supporting Survivor‐Centered Care Through Digital Health Integration

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak   +15 more
wiley   +1 more source

Sixteen practically solvable systems of difference equations

open access: yes, 2020
[[abstract]]Closed-form formulas for general solutions to sixteen hyperbolic-cotangent-type systems of difference equations of interest are obtained, showing their practical solvability and completely solving a solvability problem for some concrete ...
Stevi, Stevo;Stevic, Stevo
core  

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Home - About - Disclaimer - Privacy